Colgate-Palmolive (NYSE:CL) Shares Purchased by Zevin Asset Management LLC

Zevin Asset Management LLC boosted its stake in Colgate-Palmolive (NYSE:CL) by 5.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 139,302 shares of the company’s stock after acquiring an additional 7,793 shares during the period. Colgate-Palmolive accounts for about 1.9% of Zevin Asset Management LLC’s holdings, making the stock its 21st biggest position. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $12,664,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in CL. Diamond Hill Capital Management Inc. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $348,718,000. FMR LLC grew its holdings in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after acquiring an additional 2,674,807 shares during the period. AMF Tjanstepension AB grew its holdings in shares of Colgate-Palmolive by 1,088.8% in the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock worth $233,584,000 after acquiring an additional 2,353,268 shares during the period. Barclays PLC grew its holdings in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after acquiring an additional 2,132,747 shares during the period. Finally, State Street Corp grew its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on CL. Raymond James restated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a research note on Friday. TD Cowen reduced their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $101.72.

Colgate-Palmolive Trading Down 0.8 %

CL stock opened at $89.80 on Friday. The company has a market cap of $72.87 billion, a price-to-earnings ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The business has a fifty day simple moving average of $89.02 and a 200-day simple moving average of $94.82. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 earnings per share. On average, equities research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.